Pfizer gets new rebuff from UK cost body for cancer drug
LONDON (Reuters) - Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was tu...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/MURu5tgxVBw/story01.htm
No comments:
Post a Comment